Synovus Financial’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-158,017
| Closed | -$2.84M | – | 903 |
|
|
2022
Q3 | $2.84M | Sell |
158,017
-5,115
| -3% | -$91.9K | 0.03% | 256 |
|
|
2022
Q2 | $2.03M | Buy |
163,132
+7,956
| +5% | +$98.8K | 0.02% | 313 |
|
|
2022
Q1 | $2.07M | Buy |
155,176
+61,821
| +66% | +$824K | 0.02% | 319 |
|
|
2021
Q4 | $1.45M | Buy |
93,355
+6,919
| +8% | +$108K | 0.01% | 382 |
|
|
2021
Q3 | $1.94M | Sell |
86,436
-2,384
| -3% | -$53.4K | 0.02% | 319 |
|
|
2021
Q2 | $2.02M | Buy |
88,820
+11,030
| +14% | +$251K | 0.02% | 304 |
|
|
2021
Q1 | $1.59M | Buy |
77,790
+13,508
| +21% | +$277K | 0.02% | 306 |
|
|
2020
Q4 | $1.78M | Buy |
64,282
+4,960
| +8% | +$137K | 0.02% | 295 |
|
|
2020
Q3 | $836K | Buy |
59,322
+956
| +2% | +$13.5K | 0.01% | 373 |
|
|
2020
Q2 | $1.2M | Buy |
+58,366
| New | +$1.2M | 0.02% | 300 |
|